Drug Profile
Research programme: vaccines - Sanofi/ Gates Foundation
Latest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Developer Sanofi Pasteur
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Undefined in USA
- 29 Oct 2013 Early research in Undefined indication in USA (unspecified route)